296 related articles for article (PubMed ID: 19877197)
1. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel.
Kishimoto Y; Hirano S; Kitani Y; Suehiro A; Umeda H; Tateya I; Kanemaru S; Tabata Y; Ito J
Laryngoscope; 2010 Jan; 120(1):108-13. PubMed ID: 19877197
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.
Ohno T; Hirano S; Kanemaru S; Yamashita M; Umeda H; Suehiro A; Tamura Y; Nakamura T; Ito J; Tabata Y
Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):762-9. PubMed ID: 17987782
[TBL] [Abstract][Full Text] [Related]
3. Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor.
Mizuta M; Hirano S; Ohno S; Kanemaru S; Nakamura T; Ito J
Laryngoscope; 2014 Mar; 124(3):E81-6. PubMed ID: 24115162
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar.
Kobayashi T; Mizuta M; Hiwatashi N; Kishimoto Y; Nakamura T; Kanemaru SI; Hirano S
Auris Nasus Larynx; 2017 Feb; 44(1):86-92. PubMed ID: 27126068
[TBL] [Abstract][Full Text] [Related]
5. Growth factor therapy for vocal fold scarring in a canine model.
Hirano S; Bless DM; Nagai H; Rousseau B; Welham NV; Montequin DW; Ford CN
Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):777-85. PubMed ID: 15535139
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β3 for the prevention of vocal fold scarring.
Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Ishikawa S; Mizuta M; Tateya I; Nakamura T; Ito J
Laryngoscope; 2012 Mar; 122(3):583-9. PubMed ID: 22252900
[TBL] [Abstract][Full Text] [Related]
7. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model.
Hirano S; Bless DM; Rousseau B; Welham N; Montequin D; Chan RW; Ford CN
Laryngoscope; 2004 Mar; 114(3):548-56. PubMed ID: 15091233
[TBL] [Abstract][Full Text] [Related]
8. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
Hirano S; Bless D; Heisey D; Ford C
Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin and adhesion molecules on canine scarred vocal folds.
Hirano S; Bless DM; Rousseau B; Welham N; Scheidt T; Ford CN
Laryngoscope; 2003 Jun; 113(6):966-72. PubMed ID: 12782806
[TBL] [Abstract][Full Text] [Related]
10. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar.
Krishna P; Rosen CA; Branski RC; Wells A; Hebda PA
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):937-45. PubMed ID: 17141088
[TBL] [Abstract][Full Text] [Related]
11. Effects of hepatocyte growth factor injection and reinjection on healing in the rabbit vocal fold.
Dias Garcia RI; Tsuji DH; Imamura R; Mauad T; Ferraz da Silva LF
J Voice; 2012 Sep; 26(5):667.e7-12. PubMed ID: 22296997
[TBL] [Abstract][Full Text] [Related]
12. Lamina propria replacement therapy with cultured autologous fibroblasts for vocal fold scars.
Chhetri DK; Head C; Revazova E; Hart S; Bhuta S; Berke GS
Otolaryngol Head Neck Surg; 2004 Dec; 131(6):864-70. PubMed ID: 15577782
[TBL] [Abstract][Full Text] [Related]
13. Comparative histology and vibration of the vocal folds: implications for experimental studies in microlaryngeal surgery.
Garrett CG; Coleman JR; Reinisch L
Laryngoscope; 2000 May; 110(5 Pt 1):814-24. PubMed ID: 10807360
[TBL] [Abstract][Full Text] [Related]
14. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection.
Hertegård S; Cedervall J; Svensson B; Forsberg K; Maurer FH; Vidovska D; Olivius P; Ahrlund-Richter L; Le Blanc K
Laryngoscope; 2006 Jul; 116(7):1248-54. PubMed ID: 16826069
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional analysis of vocal fold vibration in unilaterally atrophied larynges.
Kobayashi J; Yumoto E; Hyodo M; Gyo K
Laryngoscope; 2000 Mar; 110(3 Pt 1):440-6. PubMed ID: 10718435
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute vocal fold scar with local injection of basic fibroblast growth factor: a canine study.
Suehiro A; Hirano S; Kishimoto Y; Rousseau B; Nakamura T; Ito J
Acta Otolaryngol; 2010 Jul; 130(7):844-50. PubMed ID: 20082571
[TBL] [Abstract][Full Text] [Related]
17. A new instrument for intraoperative assessment of individual vocal folds.
Heaton JT; Kobler JB; Hillman RE; Zeitels SM
Laryngoscope; 2005 Jul; 115(7):1223-9. PubMed ID: 15995511
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and safety of human recombinant hepatocyte growth factor administered to vocal folds.
Mizuta M; Hirano S; Kishimoto Y; Hiwatashi N; Tateya I; Kanemaru S; Nakamura T; Ito J
Laryngoscope; 2014 Sep; 124(9):2131-5. PubMed ID: 24668496
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in vocal functions of human scarred vocal folds after cordectomy.
Kishimoto Y; Hirano S; Tateya I; Kanemaru S; Ito J
Laryngoscope; 2010 Aug; 120(8):1597-601. PubMed ID: 20641077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]